<bill session="117" type="h" number="1186" updated="2023-01-11T13:47:19Z">
  <state datetime="2021-02-18">REFERRED</state>
  <status>
    <introduced datetime="2021-02-18"/>
  </status>
  <introduced datetime="2021-02-18"/>
  <titles>
    <title type="display">Supply Chain Security and Pharmaceutical Authentication Act of 2021</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to reduce the threat of counterfeit drugs to the pharmaceutical supply chain, and to make the pharmaceutical supply chain more robust, while ensuring the authenticity, content, purity, and manufacturing location and batch number of drugs (including COVID-19 therapeutics and vaccines) and allowing patient verification of authenticity, and for other purposes.</title>
    <title type="short" as="introduced">Supply Chain Security and Pharmaceutical Authentication Act of 2021</title>
  </titles>
  <sponsor bioguide_id="V000133"/>
  <cosponsors>
    <cosponsor bioguide_id="B001307" joined="2021-02-18"/>
    <cosponsor bioguide_id="M001190" joined="2021-10-25"/>
  </cosponsors>
  <actions>
    <action datetime="2021-02-18">
      <text>Introduced in House</text>
    </action>
    <action datetime="2021-02-18" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2021-02-19">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Manufacturing"/>
  </subjects>
  <amendments/>
  <summary date="2021-04-01T21:14:10Z" status="Introduced in House">Supply Chain Security and Pharmaceutical Authentication Act of 2021 

This bill modifies the application of requirements for drug packaging to include certain information, such as the product's lot number and expiration date.

Under the bill, the requirements shall apply to the packaging of the smallest or individual solid oral dosage form of the product. Currently, such requirements apply to the smallest container (which might contain multiple dosages) of the product that is intended for individual sale to a dispenser, such as a pharmacy.</summary>
</bill>
